Tonight’s launch positions three legacy defense contractors to prove the old guard still delivers on trillion-dollar ...

Artemis II is scheduled to launch from Launch Pad 39B at Kennedy Space Center in Florida on Wednesday, sending four ...

Solid-state lithium batteries are widely regarded as the future of safe and high-energy energy storage systems, yet their ...

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Donors to the International Chornobyl Cooperation Account (ICCA), managed by the European Bank for Reconstruction and ...

Fraunhofer IWS has developed the new “laser direct plating” process, which creates a functional layer directly on the base component by winding a strip-shaped metal spirally onto rotationally ...

BioAtla, Inc. (NASDAQ: BCAB or the "Company"), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic ...

“Truth be told, the St James Municipal Corporation has been playing a big part, over the years, in the maintenance of the ...

Initiated a formal process to monetize assets Implemented a restructuring plan to significantly reduce operating expenses and ...

Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck can ...

Moby Strategic Execution and Platform Validation. Transitioned from 'promise to proof' in 2025 by establishing clinical dur ...

The US Food and Drug Administration has cleared radiopharmaceutical company Aktis Oncology to begin trials of its B7-H3-targeting miniprotein radioconjugate, the company announced this week. Aktis ...